MERAND PHARMACEUTICALS
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease. Merand's therapeutic treats patients by promoting angiogenesis or the development of new blood vessels, which leads to restored blood flow, enabling doctors to stabilize functional blood vessels of patients to increase perfusion recovery and reduce inflammation.
MERAND PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
CAV Angels
CAV Angels investment in Seed Round - Merand Pharmaceuticals
Charlottesville Angel Network
Charlottesville Angel Network investment in Seed Round - Merand Pharmaceuticals
UVA Licensing & Ventures Group
UVA Licensing & Ventures Group investment in Seed Round - Merand Pharmaceuticals
More informations about "Merand Pharmaceuticals"
Merand Pharmaceuticals Inc.
MERAND PHARMACEUTICALS, INC. microRNA Therapeutics for Treating Peripheral Arterial Disease (PAD) and other Cardiovascular Disorders. Merand is developing a microRNA called MPMI-93 that has the potential to alter the …See details»
About us - Merand Pharmaceuticals Inc.
Founded in 2018, Merand Pharmaceuticals, Inc. is a clinical stage, privately held corporation (Delaware registered), which is developing microRNAs for unmet clinical needs in patients with vascular diseases.See details»
Merand Pharmaceuticals - Crunchbase Company Profile & Funding
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease. Merand's therapeutic treats patients by promoting angiogenesis or the development of new …See details»
Merand Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Merand Pharmaceuticals, Inc. of Charlottesville, VA. Get the latest business insights from Dun & …See details»
Merand Pharma - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Merand Pharma. Use the PitchBook Platform to explore the full profile.See details»
Merand Pharmaceuticals - Funding, Financials, Valuation & Investors
Jul 31, 2019 · Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.See details»
MERAND PHARMACEUTICALS, INC.
Currently raising $2.3M Series A1 to conduct first-in-human clinical study designed to demonstrate not only safety by also give an indication of bioactivity and provide information on …See details»
Merand Pharmaceuticals - Updates, News, Events, Signals & Triggers
Jul 31, 2019 · Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.See details»
Merand Pharmaceuticals • UVA Licensing & Ventures Group
Merand Pharmaceuticals is developing a novel microRNA therapeutic (MicroRNA93 or miR-93), which was discovered at UVA, to treat patients suffering from Peripheral Arterial Disease …See details»
Merand Pharmaceuticals • UVA Licensing & Ventures Group
Merand Pharmaceuticals is developing a novel microRNA therapeutic to treat patients suffering from Peripheral Arterial Disease, a progressive circulatory issue affecting more than 200 …See details»
Merand Pharmaceuticals - Products, Competitors, Financials, …
Merand Pharmaceuticals is a healthcare pharmaceuticals company operating in stealth mode. Use the CB Insights Platform to explore Merand Pharmaceuticals's full profile.See details»
Merand Pharmaceuticals, Inc. - fund raising filing
Jul 23, 2019 · Merand Pharmaceuticals, Inc. - Most recent fund raising on July 23, 2019 raised $1,135,000 in Equity.See details»
Merand Pharmaceuticals - Crunchbase
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.See details»
Media - Merand Pharmaceuticals Inc.
Dr. Annex is the scientific founder of Merand and is currently working with the Company as its Chief Medical Officer, providing expertise in non-clinical and clinical development.See details»
Merand Pharmaceuticals - Contacts, Employees, Board Members, …
Merand Pharmaceuticals has 3 current employee profiles, including Co-Founder Brian Annex. Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.See details»
Technology - Merand Pharmaceuticals Inc.
Company ready to initiate First-in-Human, Phase 1, study with lead microRNA product MPMI-93 in patients with Peripheral Arterial Disease (PAD).See details»
Merand Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
Jul 23, 2019 · See Merand Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Merand Pharmaceuticals's post-money valuation and …See details»
Peripheral vascular disease: preclinical models and emerging ...
Jun 17, 2021 · BH Annex is the founder of Merand Pharmaceuticals which is seeking to develop microRNAs for PAD. VC Ganta received a grant from Merand Pharm.See details»
Anthony Giordano - Co-Founder @ Merand Pharmaceuticals
Anthony Giordano is the Co-Founder of Merand Pharmaceuticals. Start Free Trial . Chrome ExtensionSee details»
Chuke Nwachuku - Chief Development Officer and VP @ Merand ...
Chuke Nwachuku is the Chief Development Officer and VP at Merand Pharmaceuticals. Additionally, Chuke Nwachuku has had 1 past job as the Director of Regulatory Affairs at …See details»